Skip to content
Ransomware

Biomedical Caledonia Medical Laboratory listed on Inc Ransom leak site

Biomedical Caledonia Medical Laboratory has been listed on the Inc Ransom leak site, following allegations of a data breach.

By
Siberpol Intelligence Unit
Published
2 min read
2 min read
  • Ransomware group: Inc Ransom
  • Country: Jamaica
  • Sector: Healthcare
  • Announcement date: January 14, 2025

Biomedical Caledonia Medical Laboratory has been listed on the Inc Ransom leak site following allegations of a data breach. The threat actor known as Inc Ransom claims to have compromised data belonging to the organization and has published this information on their dedicated leak site.

The details of the claim

According to the announcement, the incident involving Biomedical Caledonia Medical Laboratory is linked to a breach that allegedly occurred on November 2, 2024. The listing itself was created on January 13, 2025. This significant time gap between the claimed attack date and the public announcement is a common occurrence in cyberattack lifecycles.

The threat actor, identified as Inc Ransom, appears to be utilizing double-extortion tactics in this instance. Double extortion is a common ransomware strategy where attackers not only encrypt an organization's data to disrupt operations but also steal sensitive information beforehand. The attackers then threaten to leak the stolen data on a public website if the ransom is not paid. This method is designed to increase pressure on the victim organization by threatening their reputation and legal standing through the exposure of private information.

Data involved in the incident

The information provided by the threat actor regarding the specific contents of the breach remains limited. The listing includes screenshots that display samples of various documents and reports related to the organization's operations. However, there is no detailed information regarding the full scope or specific types of the compromised data. The listing names no specific data types.

Information regarding the breach

  • No specific data types were identified in the listing.

About Biomedical Caledonia Medical Laboratory

Biomedical Caledonia Medical Laboratory is a private medical laboratory that has been operating since 1968. The organization maintains a significant presence in Jamaica, operating a network of 46 collection centres across the country. It provides comprehensive laboratory services and participates in external proficiency testing to maintain its service standards.

Implications and defensive considerations

This incident suggests that sensitive data belonging to a healthcare organization may have been compromised. The disclosure of such data could violate the privacy of patient medical records and may create secondary risks for individuals, such as identity theft. Because the organization operates within a specific jurisdiction, the disclosure of this information may trigger legal processes under the data protection regulations applicable to the region where the organization operates.

The use of the double-extortion method by the Inc Ransom group could negatively impact the organization's operational continuity and reputation. For organizations operating in the healthcare sector, such incidents highlight the critical importance of robust data security measures. To mitigate such risks, organizations often focus on several defensive pillars:

  • Data encryption: Ensuring that sensitive data is encrypted both at rest and in transit to prevent it from being useful if exfiltrated.
  • Access controls: Implementing strict identity and access management to ensure only authorized personnel can access sensitive medical records.
  • Network monitoring: Maintaining continuous visibility into network traffic to detect unauthorized data exfiltration attempts.
  • Regular audits: Conducting frequent security assessments and reviews of data protection protocols.

As seen in this case, the potential for secondary risks to individuals means that healthcare providers must prioritize the protection of patient confidentiality to maintain public trust and comply with regional legal frameworks.

From the Essential plan

Third-Party Risk

Monitor leaks on your suppliers’ domains and identify at-risk suppliers at an early stage.

Related stories